0001209191-17-036937.txt : 20170601
0001209191-17-036937.hdr.sgml : 20170601
20170601191708
ACCESSION NUMBER: 0001209191-17-036937
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170531
FILED AS OF DATE: 20170601
DATE AS OF CHANGE: 20170601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNAPTICS Inc
CENTRAL INDEX KEY: 0000817720
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
IRS NUMBER: 770118518
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0627
BUSINESS ADDRESS:
STREET 1: 1251 MCKAY DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95131-3326
BUSINESS PHONE: 408-904-1100
MAIL ADDRESS:
STREET 1: 1251 MCKAY DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95131-3326
FORMER COMPANY:
FORMER CONFORMED NAME: SYNAPTICS INC
DATE OF NAME CHANGE: 20010216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bergman Rick
CENTRAL INDEX KEY: 0001321224
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-49602
FILM NUMBER: 17886087
MAIL ADDRESS:
STREET 1: 1251 MCKAY DRIVE
CITY: SAN JOSE
STATE: CA
ZIP: 95131
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-31
0
0000817720
SYNAPTICS Inc
SYNA
0001321224
Bergman Rick
1251 MCKAY DRIVE
SAN JOSE
CA
95131
1
1
0
0
President and CEO
Common Stock
2017-05-31
4
M
0
10000
23.25
A
105728
D
Common Stock
2017-05-31
4
S
0
9200
55.5334
D
96528
D
Common Stock
2017-05-31
4
S
0
800
56.4913
D
95728
D
Employee Stock Option (Right to Buy)
23.25
2017-05-31
4
M
0
10000
0.00
D
2018-09-28
Common Stock
10000
57500
D
Includes 240 shares acquired under the Issuer's employee stock purchase plan in May 2017.
The shares were sold pursuant to a 10b5-1 Trading Plan dated August 22, 2016.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.04 to $56.02, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.09 to $56.60, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
25% of the total number of shares subject to the option vested and became exercisable on the twelve month anniversary of the September 28, 2011 grant date, and 1/48th of the total number of shares subject to the option vested and became exercisable on the 28th day of each month thereafter, until fully vested on September 28, 2015.
Kermit Nolan, as attorney-in-fact
2017-06-01